Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1974-1987
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1974
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1974
Name | Primer sequences |
CDKN2B-AS1 | Forward: 5’-AGGAGGCTGAATGTCAGTTTT-3’ |
Reverse: 5’-AGCGGTTTAGTTTAATTTCGCTT-3’ | |
E2F1 | Forward: 5’-GGACCUGGAAACUGACCAUTT-3’ |
Reverse: 5’-GACCACCUGAUGAAUAUCUTT-3’ | |
GNAZ | Forward: 5’-GGTCTACATCCAACGTCAGTTC-3’ |
Reverse: 5’-TCTGTCACTGCGTCAAACAC-3’ | |
GAPDH | Forward: 5’-TCTTCACCACCATGGAGAAG-3’ |
Reverse: 5’-GCAGAGATGATGACCCTTTTG-3’ | |
U6 | Forward: 5’-GCTTCGGCAGCACATATACTAAAAT-3’ |
Reverse: 5’-CGCTTCACGAATTTGCGTGTCAT-3’ |
- Citation: Tao ZG, Yuan YX, Wang GW. Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1/G protein subunit alpha Z axis. World J Gastrointest Oncol 2023; 15(11): 1974-1987
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1974.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1974